Literature DB >> 3236267

Validity of the General Health Questionnaire and its subscales in patients receiving chemotherapy for early breast cancer.

A V Hughson1, A F Cooper, C S McArdle, D C Smith.   

Abstract

The performance of the General Health Questionnaire as a case detector was assessed in 75 patients receiving chemotherapy for early breast cancer. The questionnaire and its subscales were found to be valid when compared with observer ratings. The misclassification rate of the 60-item version of the questionnaire was lowest when the standard threshold score for clinical morbidity was doubled to 24. It was lowest for the 28-item version when the threshold score was doubled to 10. Suggested threshold scores for clinical morbidity for the subscales are: anxiety and insomnia subscale 6/7; severe depression subscale 2/3; somatic symptoms subscale 6/7; and social dysfunction subscale 7/8. However, lower thresholds would be appropriate if the questionnaire were used as screening instrument prior to interview by a trained observer.

Entities:  

Mesh:

Year:  1988        PMID: 3236267     DOI: 10.1016/0022-3999(88)90022-0

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  3 in total

Review 1.  Case identification of depression in patients with chronic physical health problems: a diagnostic accuracy meta-analysis of 113 studies.

Authors:  Nicholas Meader; Alex J Mitchell; Carolyn Chew-Graham; David Goldberg; Maria Rizzo; Victoria Bird; David Kessler; Jon Packham; Mark Haddad; Stephen Pilling
Journal:  Br J Gen Pract       Date:  2011-12       Impact factor: 5.386

2.  Psychological support for patients undergoing breast cancer surgery: a randomised study.

Authors:  J M McArdle; W D George; C S McArdle; D C Smith; A R Moodie; A V Hughson; G D Murray
Journal:  BMJ       Date:  1996-03-30

Review 3.  Screening for emotional distress in cancer patients: a systematic review of assessment instruments.

Authors:  Andrea Vodermaier; Wolfgang Linden; Christopher Siu
Journal:  J Natl Cancer Inst       Date:  2009-10-13       Impact factor: 13.506

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.